BU PhD student Anita Immanuel has been invited to speak at the 4th Annual Saudi Hematology/Oncology Nurses Meeting in Jeddah, Saudi Arabia this Saturday (May 7th). Anita’s Ph.D. study examines the quality of lives of adults who have survived cancer of the blood or lymphatic system. Patients with haematological cancers have frequently reported lack of care-coordination as an unmet need following their intensive treatment. With the increase in the number of cancer survivors and possible long-term side effects that could impact on the quality of life, it is important to have (a) good post-treatment follow up; and (b) seamless coordination between health care providers.
Dr. Helen McCarthy (The Royal Bournemouth and Christchurch Hospitals NHS Foundation Trust), Anita’s clinical Ph.D. supervisor at congratulated her on this invitation. Dr. McCarthy said: “This talk in Saudi Arabia gives Anita the opportunity to present some of her preliminary Ph.D. findings.”
FHSS’s Dr. Jane Hunt commented: “Anita’s research is addressing a growing issue with more people living longer with cancer. Her Ph.D. identifies key quality of life issues and helps us to understand the needs surrounding survivorship care better.”
Prof. Edwin van Teijlingen
CMMPH
Winston Churchill Memorial Trust Travel Fellowship: Anita Immanuel










Four BU students at national midwifery conference
INRC book roundtable/presentation by Drs Jonathan Cole and Catherine Talbot, Wednesday 22/04/2026, 13:00h, P426
BU M.Res. student’s evidence to UK Parliamentary Women & Equalities Committee
Prof Marahatta promoting BU-Nepal collaboration
3C Online Social: Research Culture, Community & Can you Guess Who? Thursday 26 March 1-2pm
ECR Funding Open Call: Research Culture & Community Grant – Apply now
ECR Funding Open Call: Research Culture & Community Grant – Application Deadline Friday 12 December
MSCA Postdoctoral Fellowships 2025 Call
ERC Advanced Grant 2025 Webinar
Update on UKRO services
European research project exploring use of ‘virtual twins’ to better manage metabolic associated fatty liver disease